Europe In-Vitro Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Product & Services (Reagents & Kits, Instruments, and Software & Services), Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others), and End User (Hospitals, Laboratories, Homecare, and Others)

No. of Pages: 124    |    Report Code: TIPRE00022122    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe In-Vitro Diagnostics Market

1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Europe In-Vitro Diagnostics Market - Key Industry Dynamics

4.1       Key Market Drivers

4.1.1         Increasing Prevalence of Chronic and Infectious Diseases

4.1.2         Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic

4.2       Market Restraint

4.2.1         Insufficiency of Regulatory Frameworks and Reimbursement Policies

4.3       Market Opportunities

4.3.1         Integration of IVD with Digital Health Technologies

4.4       Future Trends

4.4.1         Increasing Demand for Personalized Medicine and Genomics

5.           In-Vitro Diagnostics Market - Europe Market Analysis

5.1       Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 – 2030

6.           Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services

6.1       Overview

6.2       Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

6.3       Reagents and Kits

6.3.1         Overview

6.3.2         Reagents and Kits: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

6.4       Software and Services

6.4.1         Overview

6.4.2         Software and Services: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Instruments

6.5.1         Overview

6.5.2         Instruments: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.           Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Technology

7.1       Overview

7.2       Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

7.3       Immunoassay/ Immunochemistry

7.3.1         Overview

7.3.2         Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.4       Clinical Chemistry

7.4.1         Overview

7.4.2         Clinical Chemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.5       Molecular Diagnostics

7.5.1         Overview

7.5.2         Molecular Diagnostics: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.6       Microbiology

7.6.1         Overview

7.6.2         Microbiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.7       Blood Glucose Self-Monitoring

7.7.1         Overview

7.7.2         Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.8       Coagulation and Hemostasis

7.8.1         Overview

7.8.2         Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.9       Hematology

7.9.1         Overview

7.9.2         Hematology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.10     Urinalysis

7.10.1       Overview

7.10.2       Urinalysis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

7.11     Others

7.11.1       Overview

7.11.2       Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.           Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by Application

8.1       Overview

8.2       Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

8.3       Infectious Disease

8.3.1         Overview

8.3.2         Infectious Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4       Diabetes

8.4.1         Overview

8.4.2         Diabetes: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5       Oncology

8.5.1         Overview

8.5.2         Oncology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.6       Cardiology

8.6.1         Overview

8.6.2         Cardiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.7       Autoimmune Diseases

8.7.1         Overview

8.7.2         Autoimmune Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.8       Nephrology

8.8.1         Overview

8.8.2         Nephrology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.9       Others

8.9.1         Overview

8.9.2         Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.           Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – by End User

9.1       Overview

9.2       Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

9.3       Hospitals

9.3.1         Overview

9.3.2         Hospitals: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4       Laboratories

9.4.1         Overview

9.4.2         Laboratories: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.5       Homecare

9.5.1         Overview

9.5.2         Homecare: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.6       Others

9.6.1         Overview

9.6.2         Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.        Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 – Country Analysis

10.1     Europe In-Vitro Diagnostics Market

10.1.1       Overview

10.1.2       Europe In-Vitro Diagnostics Market, by Country

10.1.2.1          Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.1        Overview

10.1.2.1.2        Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.1.3        Germany: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.1.4        Germany: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.1.5        Germany: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.1.6        Germany: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.2          France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.1        Overview

10.1.2.2.2        France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.2.3        France: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.2.4        France: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.2.5        France: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.2.6        France: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.3          UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.1        Overview

10.1.2.3.2        UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.3.3        UK: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.3.4        UK: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.3.5        UK: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.3.6        UK: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.4          Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.1        Overview

10.1.2.4.2        Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.4.3        Italy: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.4.4        Italy: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.4.5        Italy: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.4.6        Italy: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.5          Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.5.1        Overview

10.1.2.5.2        Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.5.3        Spain: Europe In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.5.4        Spain: Europe In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.5.5        Spain: Europe In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.5.6        Spain: Europe In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

10.1.2.6          Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.6.1        Overview

10.1.2.6.2        Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.2.6.3        Rest of Europe: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)

10.1.2.6.4        Rest of Europe: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)

10.1.2.6.5        Rest of Europe: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)

10.1.2.6.6        Rest of Europe: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)

11.        Industry Landscape

11.1     Organic Developments

11.1.1       Overview

11.2     Inorganic Developments

11.2.1       Overview

12.        Company Profiles

12.1     Abbott Laboratories

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2     F. Hoffmann-La Roche Ltd

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3     Danaher Corp

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4     Siemens AG

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5     Sysmex Corp

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6     Thermo Fisher Scientific Inc

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7     Becton Dickinson and Co

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8     bioMerieux SA

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9     Bio-Rad Laboratories Inc

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

12.10  Qiagen NV

12.10.1    Key Facts

12.10.2    Business Description

12.10.3    Products and Services

12.10.4    Financial Overview

12.10.5    SWOT Analysis

12.10.6    Key Developments

13.        Appendix

13.1     About Us

13.2     Glossary of Terms

 

 

 

 

List of Tables

Table 1.             Europe In-Vitro Diagnostics Market Segmentation

Table 2.             Germany Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 3.             Germany Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 4.             Germany Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 5.             Germany Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 6.             France Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 7.             France Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 8.             France Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 9.             France Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 10.          UK Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 11.          UK Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 12.          UK Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 13.          UK Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Italy Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Italy Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Italy Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Italy Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 18.          Spain Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 19.          Spain Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 20.          Spain Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 21.          Spain Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 22.          Rest of Europe Europe In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)

Table 23.          Rest of Europe Europe In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 24.          Rest of Europe Europe In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)

Table 25.          Rest of Europe Europe In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 26.          Organic Developments Done by Companies

Table 27.          Inorganic Developments Done by Companies

Table 28.          Glossary of Terms, Europe In-Vitro Diagnostics Market

 

 

List of Figures

Figure 1.           Europe In-Vitro Diagnostics Market Segmentation, By Country

Figure 2.           Europe In-Vitro Diagnostics Market: Key Industry Dynamics

Figure 3.           Europe In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 4.           Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 – 2030

Figure 5.           Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)

Figure 6.           Reagents and Kits: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Software and Services: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Instruments: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 10.        Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Clinical Chemistry: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Molecular Diagnostics: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Microbiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 14.        Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Hematology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Urinalysis: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 19.        Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)

Figure 20.        Infectious Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Diabetes: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22.        Oncology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Cardiology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Autoimmune Diseases: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Nephrology: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 26.        Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 27.        Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)

Figure 28.        Hospitals: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Laboratories: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Homecare: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        Others: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Europe In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 33.        Europe In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)

Figure 34.        Germany: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 35.        France: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 36.        UK: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 37.        Italy: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 38.        Spain: Europe In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

Figure 39.        Rest of Europe: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

 

The List of Companies - Europe In-Vitro Diagnostics Market

  1. Abbott Laboratories 
  2. F. Hoffmann-La Roche Ltd 
  3. Danaher Corp 
  4. Siemens AG
  5. Sysmex Corp 
  6. Thermo Fisher Scientific Inc 
  7. Becton Dickinson and Co
  8. bioMerieux SA 
  9. Bio-Rad Laboratories Inc
  10. Qiagen NV